Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Camilla Molich Hoff. (2012) Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Acta Oncologica 51:4, pages 419-432.
Read now
Read now
Articles from other publishers (33)
Christine Gennigens, Marjolein De Cuypere, Laurence Seidel, Johanne Hermesse, Annelore Barbeaux, Frédéric Forget, Adelin Albert, Guy Jerusalem & Frédéric Kridelka. (2020) Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy. Cancer Medicine 9:22, pages 8432-8443.
Crossref
Crossref
Miaoling Huang, Qing Chen, Jianpeng Xiao, Tingting Yao, Lijuan Bian, Changhao Liu & Zhongqiu Lin. (2014) Overexpression of Hypoxia-Inducible Factor-1α Is a Predictor of Poor Prognosis in Cervical Cancer: A Clinicopathologic Study and a Meta-analysis. International Journal of Gynecologic Cancer 24:6, pages 1054-1064.
Crossref
Crossref
Kay A. Criswell, Jeffrey H. Bock, Samantha E. Wildeboer, Kjell Johnson & Richard P. Giovanelli. (2014) Comparison of the Sysmex XT-2000iV and microscopic bone marrow differential counts in Wistar rats treated with cyclophosphamide, erythropoietin, or serial phlebotomy. Veterinary Clinical Pathology 43:2, pages 137-153.
Crossref
Crossref
D. Rades & S. E. Schild. (2012) Challenges of anemia correction during radiotherapy and chemoradiation. memo - Magazine of European Medical Oncology 5:1, pages 35-38.
Crossref
Crossref
R. Mazeron, J. Bourhis & E. Deutsch. (2008) Angiogenèse et radiothérapie : tout ce qu’un oncologue radiothérapeute doit savoir. Cancer/Radiothérapie 12:1, pages 50-60.
Crossref
Crossref
Jürgen Dunst. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
615
634
.
Peter Vaupel, Arnulf Mayer & Michael Höckel. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
265
282
.
M. Mittelbronn, D. Capper, B. Bunz, K. Dietz, B. Goeppert, R. Ajaaj, G. Tabatabai, F. Stubenvoll, H. Schlaszus, A. S. Merseburger, R. Becker, D. Freudenstein, W. Wick, M. Weller, R. Meyermann & P. Simon. (2007) De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival. Neuropathology and Applied Neurobiology 33:3, pages 299-307.
Crossref
Crossref
J. Dunst, E. Metzen & D. Rades. (2007) Erythropoetin in der StrahlentherapieErythropoietin in radiation therapy. Der Onkologe 13:2, pages 143-149.
Crossref
Crossref
Matthias Bache, Daniel Holzapfel, Matthias Kappler, Hans-Jürgen Holzhausen, Helge Taubert, Jürgen Dunst & Gabriele Hänsgen. (2007) Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy. Gynecologic Oncology 104:1, pages 139-144.
Crossref
Crossref
Stuart C. Winter, Ketan A. Shah, Cheng Han, Leticia Campo, Helen Turley, Russell Leek, Rogan J. Corbridge, Graham J. Cox & Adrian L. Harris. (2006) The relation between hypoxia‐inducible factor (HIF)‐1α and HIF‐2α expression with anemia and outcome in surgically treated head and neck cancer. Cancer 107:4, pages 757-766.
Crossref
Crossref
Michael I. Koukourakis, Alexandra Giatromanolaki, Alexandros Polychronidis, Costantinos Simopoulos, Kevin C. Gatter, Adrian L. Harris & Efthimios Sivridis. (2006) Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer. Cancer Science 97:7, pages 582-588.
Crossref
Crossref
Robert Semrau, Rolf-Peter Mueller, Hartmut Stuetzer, Susanne Staar, Ursula Schroeder, Orlando Guntinas-Lichius, Martin Kocher, Hans Theodor Eich, Andreas Dietz, Michael Flentje, Volker Rudat, Peter Volling, Michael Schroeder & Hans Edmund Eckel. (2006) Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: Updated results of a randomized multicentric trial in advanced head-and-neck cancer. International Journal of Radiation Oncology*Biology*Physics 64:5, pages 1308-1316.
Crossref
Crossref
Ilse J. Hoogsteen, Lucas A.M. Pop, Henri A.M. Marres, Matthijs A.W. Merkx, Franciscus J.A. van den Hoogen, Albert J. van der Kogel & Johannes H.A.M. Kaanders. (2006) Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology*Biology*Physics 64:1, pages 83-89.
Crossref
Crossref
Javier Valencia Julve, Vicente Alonso Orduña, Ricardo Escó Barón, Miriam López-Mata & Agustina Méndez Villamón. (2006) Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy. Clinical and Translational Oncology 8:1, pages 22-30.
Crossref
Crossref
Se Hoon Park, Jeeyun Lee, Se Hoon Lee, Joon Oh Park, Kihyun Kim, Won Seog Kim, Chul Won Jung, Young Suk Park, Won Ki Kang, Keunchil Park, Seonwoo Kim, Soo Mee Bang, Eun Kyung Cho, Dong Bok Shin & Jae Hoon Lee. (2005) Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemotherapy and Pharmacology 57:1, pages 91-96.
Crossref
Crossref
Stuart C. Winter, Ketan A. Shah, Leticia Campo, Helen Turley, Russell Leek, Rogan J. Corbridge, Graham J. Cox & Adrian L. Harris. (2005) Relation of Erythropoietin and Erythropoietin Receptor Expression to Hypoxia and Anemia in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research 11:21, pages 7614-7620.
Crossref
Crossref
Susannah Yovino, Young Kwok, Mark Krasna, Madan Bangalore & Mohan Suntharalingam. (2005) An association between preoperative anemia and decreased survival in early-stage non–small-cell lung cancer patients treated with surgery alone. International Journal of Radiation Oncology*Biology*Physics 62:5, pages 1438-1443.
Crossref
Crossref
Claudio Otón Sánchez, Gilberto Peñate González & Luis Fernando Otón Sánchez. (2005) Eritropoyetina en la anemia del paciente oncológico. Luces y sombras. Medicina Clínica 124:5, pages 186-195.
Crossref
Crossref
Ricardo Escó Barón, Javier Valencia Julve, Sonia Polo Jaime, Natividad Bascón Santaló, Carmen Velilla Millán & Miriam López Mata. (2019) Hemoglobin Levels and Acute Radiotherapy-Induced Toxicity. Tumori Journal 91:1, pages 40-45.
Crossref
Crossref
Peter Vaupel, Jürgen Dunst, Andreas Engert, Joachim Fandrey, Petra Feyer, Mathias Freund & Wolfgang Jelkmann. (2005) Effects of Recombinant Human Erythropoietin (rHuEPO) on Tumor Control in Patients with Cancer-Induced Anemia. Oncology Research and Treatment 28:4, pages 216-221.
Crossref
Crossref
Alexandre I. Belenkov, George Shenouda, Ekatarina Rizhevskaya, Denis Cournoyer, Jean-Philippe Belzile, Luis Souhami, Slobodan Devic & Terry Y.K. Chow. (2004) Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin. Molecular Cancer Therapeutics 3:12, pages 1525-1532.
Crossref
Crossref
Juergen Dunst, Thomas Kuhnt, Hans G Strauss, Ulf Krause, Tanja Pelz, Heinz Koelbl & Gabriele Haensgen. (2003) Anemia in cervical cancers: Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. International Journal of Radiation Oncology*Biology*Physics 56:3, pages 778-787.
Crossref
Crossref
Georg Stüben, Christoph Pöttgen, Kai Knühmann, Kai Schmidt, Martin Stuschke, Oliver Thews & Peter Vaupel. (2003) Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice. International Journal of Radiation Oncology*Biology*Physics 55:5, pages 1358-1362.
Crossref
Crossref
J. Dunst. 2003. Modification of Radiation Response. Modification of Radiation Response
89
101
.
Ulrich D??hrsen. (2002) The Clinical Value of Erythropoietin in Patients with Cancer. Drugs 62:14, pages 2013-2023.
Crossref
Crossref
Jürgen Dunst & M. Molls. 2002. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
117
125
.
Anthony W. Fyles, Michael Milosevic, Melania Pintilie, Ami Syed & Richard P. Hill. (2000) Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiotherapy and Oncology 57:1, pages 13-19.
Crossref
Crossref
Michael I Koukourakis, Alexandra Giatromanolaki, Efthimios Sivridis & Ioannis Fezoulidis. (2000) Cancer vascularization: implications in radiotherapy?. International Journal of Radiation Oncology*Biology*Physics 48:2, pages 545-553.
Crossref
Crossref
Axel Becker, Peter Stadler, Robert S Lavey, Gabriele Hänsgen, Thomas Kuhnt, Christine Lautenschläger, Horst Jürgen Feldmann, Michael Molls & Jürgen Dunst. (2000) Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. International Journal of Radiation Oncology*Biology*Physics 46:2, pages 459-466.
Crossref
Crossref
C. Grau & J. Overgaard. 2000. Blood Perfusion and Microenvironment of Human Tumors. Blood Perfusion and Microenvironment of Human Tumors
101
112
.
Peter Vaupel, DebraK Kelleher & Oliver Thews. (1998) Modulation of tumor oxygenation. International Journal of Radiation Oncology*Biology*Physics 42:4, pages 843-848.
Crossref
Crossref
Christopher G. Milross, Lester J. Peters, Nancy R. Hunter, Kathryn A. Mason, Susan L. Tucker & Luka Milas. (1996) Polarographic pO2 measurement in mice:Effect of tumor type, site of implantation, and anesthesia. Radiation Oncology Investigations 4:3, pages 108-114.
Crossref
Crossref